News of review ordered by King Abdullah send Israeli gas shares lower; sources tell Saudi newspaper that the Jordanian royal was using the report to pressure Israel
Jacob Frenkel not interested in returning to the Bank of Israel, associates say ■ After years of delay, Bezeq to begin wholesaling landline phone service ■ Delek Group to start drilling in Gulf of Mexico within the week
Israeli gas companies in Tel Aviv losing four-to-five percent in midday trading on possible suspicion that developing the Noor field will hurt Leviathan's prospects
Delek Royalties meets strong demand in maiden bond sale ■ Marijuana shares plummet after exchange refuses to include Together in share indices ■ Pointer teaming up with Microsoft to use AI to understand driver behavior ■ Insurance and energy shares weigh on Tel Aviv market
Tamar gas field partners earned record $1.1 billion last year ■ Orbotech will pay $125 million fee if KLA-Tencor takeover is cancelled ■ High fuel and wage costs leave El Al with bigger loss Tel Aviv shares end lower ahead of expected Fed rate hike
Teva reveals share, option holdings of directors, executives ■ Oil Refineries gets nod to develop $200 million gas-fired power plant ■ Adom Finance abandons pioneering issue of bonds to be invested in bank deposits ■ Tel Aviv shares end lower as dollar gains on intervention
The ultra-Orthodox owned company is now the 27th U.S. real estate firm to have bonds traded in Tel Aviv
Three arrested as protesters in Tel Aviv call for transparency in the decision-making process regarding gas, disbandment of Nobel-Delek monopoly and lowering of gas price to consumers.
Billionaire's representatives met last week with Delek and Noble, which have rights to the fields.
Investment house predicts another strong year for TASE with shares still attractively priced.
Dip follows Bank of Israel’s announcement of plans to increase bank transparency.
German election results and Fed’s stimulus program helping to buoy the market
Ramon used to be a minister and one of Kadima's top politicians before leaving politics in 2009.
Some think a U.S. attack on Syria would be precisely the time to get into stocks.
Israel Chemicals rose 1.4% as is weighs $500 million dividend after 2Q profit plunges.
Shares of local generic drugmaker fall 4.4% after $8.6 billion buy of Irish biotech firm Elan